Amy Schulman
(Ms. Amy Schulman J.D.)
Hält derzeit Positionen bei SQZ Biotechnologies Co and Alnylam Pharmaceuticals Inc
Position
| Position | Company | Period |
|---|---|---|
| Executive Chairman | SQZ Biotechnologies Co | None - |
| Independent Director | Alnylam Pharmaceuticals Inc | 1. Juli 2014 - |
| Independent Director | Ironwood Pharmaceuticals Inc | 1. Januar 2017 - 1. April 2019 |
| Lead Independent Director | X4 Pharmaceuticals Inc | 1. Februar 2015 - 13. März 2019 |
| Independent Director | Blue Buffalo Pet Products Inc | 1. Januar 2014 - 24. April 2018 |
| Executive Vice President, General Counsel, Business Unit Lead - Consumer Healthcare | Pfizer Inc | 1. August 2012 - 17. Dezember 2013 |
| Director | Zoetis Inc | 1. Juli 2012 - 24. Juni 2013 |
| Executive Vice President, General Counsel, President and General Manager - Nutrition | Pfizer Inc | 1. Dezember 2010 - 1. August 2012 |
Amy Schulman's trades of Fractyl Health Inc's stock
Loading...
•
Kauf
•
Verkauf
•
Geplanter Kauf
•
Geplanter Verkauf
Netto-Kauf
Netto-Verkauf
Earnings
Abkürzungen K: Kauf, V: Verkauf, GK: Geplanter Kauf, GV: Geplanter Verkauf, S: Sonstiges
